← Browse by Condition
Medical Condition

aortic stenosis

Total Trials
11
Recruiting Now
11
Trial Phases
Phase 3, Phase 4

ClinicalMetric tracks all active clinical trials for aortic stenosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — aortic stenosis Clinical Trials

How many clinical trials are currently recruiting for aortic stenosis?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for aortic stenosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for aortic stenosis?
aortic stenosis research spans Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a aortic stenosis clinical trial?
Eligibility criteria for aortic stenosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Phase 4
1
Top Sponsors
Beijing Anzhen Hospital 2 trials
Rigshospitalet, Denmark 1 trial
Hippocration General Hospital 1 trial
Abbott Medical Devices 1 trial
Edwards Lifesciences 1 trial

Recruiting Clinical Trials

NCT06768008
Recruiting
An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
Enrollment
10,000 pts
Location
China
Sponsor
Beijing Anzhen Hospital
View Trial →
NCT06638268
Recruiting
Transcatheter AortiC Valve Implantation in aorTic stenosIs CardiogenIc Shock
Enrollment
30 pts
Location
Denmark
Sponsor
Rigshospitalet, Denmark
View Trial →
NCT07052071
Recruiting
Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis
Enrollment
40 pts
Location
Greece
Sponsor
Hippocration General Hospital
View Trial →
NCT06008080
Recruiting
Post-Market Clinical Follow Up Study With Navitor Valve
Enrollment
1,000 pts
Location
Australia, France, G...
Sponsor
Abbott Medical Devices
View Trial →
NCT04968509 Phase 3
Recruiting
Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
Enrollment
160 pts
Location
China
Sponsor
Beijing Anzhen Hospital
View Trial →
NCT03003299
Recruiting
PARTNER 3 Trial - Aortic Valve-in-Valve
Enrollment
125 pts
Location
United States, Canad...
Sponsor
Edwards Lifesciences
View Trial →
NCT05886517
Recruiting
Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk.
Enrollment
200 pts
Location
Italy, Spain
Sponsor
AUSL Romagna Rimini
View Trial →
NCT04454177
Recruiting
SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement
Enrollment
100 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
View Trial →
NCT04913870 Phase 4
Recruiting
Angiotensin Receptor Blockers in Aortic Stenosis
Enrollment
144 pts
Location
Canada, Denmark
Sponsor
Institut universitaire de card...
View Trial →
NCT07620925
Recruiting
Derivation and Validation of the Aortic Valve Echocardiographic Calcium Score to Confirm Severe Aortic Stenosis: the Echo-AVCS Study
Enrollment
250 pts
Location
Italy
Sponsor
Azienda Ospedaliera "Sant'Andr...
View Trial →
NCT07794436
Recruiting
Association Between Changes in Aortic Valve Area and Pulmonary Congestion After Transcatheter Aortic Valve Implantation
Enrollment
52 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul University - Cerrahpa...
View Trial →

Related Conditions

congenital heart disease (1) coarctation of aorta (1) pulmonary atresia (1) pulmonary stenosis (1) transposition of the great arteries (1) truncus arteriosus (1) single ventricle (1) tetralogy of fallot tof (1) interrupted aortic arch (1) hypoplastic left heart syndrome hlhs (1) total anomalous pulmonary venous connection (1) cardiogenic shock (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology